Inventor · disambiguated record
Moussa B. H. Youdim
Also filed as: BEN-SHACHAR DORIT · YOUDIM MOUSSA · YOUDIM MOUSSA B · YOUDIM MOUSSA B H
33 granted patents·16 pending applications·1,913 citations·filing 1984–2018
98Inventor score
Files withTEVA PHARMA19TECHNION RES & DEV FOUNDATION9YOUDIM MOUSSA B H4N TO B LTD2YISSUM RES DEV CO2
Top patents by PatentIndex Score
49 records- 0197US6630514B2Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 2001·Granted Oct 7, 2003·77 cites·36 claims
- 0297US5532415AR-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted Jul 2, 1996·169 cites·1 claims
- 0397US5519061AR-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereofTEVA PHARMA·Filed 1995·Granted May 21, 1996·139 cites·9 claims
- 0496US5457133AR-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing themTEVA PHARMA·Filed 1994·Granted Oct 10, 1995·112 cites·14 claims
- 0596US5453446AUse of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.TEVA PHARMA·Filed 1994·Granted Sep 26, 1995·104 cites·20 claims
- 0695US6956060B2Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTECHNION RES & DEV FOUNDATION·Filed 2002·Granted Oct 18, 2005·57 cites·5 claims
- 0795US6528685B2Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1999·Granted Mar 4, 2003·47 cites·25 claims
- 0895US6462222B1Aminoindan derivativesYISSUM RES DEV CO·Filed 2001·Granted Oct 8, 2002·82 cites·8 claims
- 0995US6316504B1Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTECHNION RES & DEV FOUNDATION·Filed 1996·Granted Nov 13, 2001·98 cites·12 claims
- 1095US5914349ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1995·Granted Jun 22, 1999·50 cites·18 claims
- 1195US5891923AR-enantiomer of N-propargyl-1-aminoindan for the treatment of dementiaTEVA PHARMA·Filed 1995·Granted Apr 6, 1999·97 cites·10 claims
- 1295US5877221ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 2, 1999·52 cites·29 claims
- 1395US5786390APharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindanTEVA PHARMA·Filed 1995·Granted Jul 28, 1998·105 cites·19 claims
- 1495US5744500AUse of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereofTEVA PHARMA·Filed 1995·Granted Apr 28, 1998·100 cites·39 claims
- 1595US5668181AUse of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depressionTEVA PHARMA·Filed 1995·Granted Sep 16, 1997·92 cites·7 claims
- 1695US5576353AMethod of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compoundsTEVA PHARMA·Filed 1995·Granted Nov 19, 1996·101 cites·7 claims
- 1794US5994408ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Nov 30, 1999·54 cites·32 claims
- 1894US5599991AEsylate and sulfate salts of R(+)-N-propargyl-1-aminoindanTEVA PHARMA·Filed 1995·Granted Feb 4, 1997·84 cites·2 claims
- 1993US5880159ACompositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivativesTEVA PHARMA·Filed 1997·Granted Mar 9, 1999·47 cites·29 claims
- 2090US6538025B2Aminoindan derivativesTEVA PHARMA·Filed 2001·Granted Mar 25, 2003·31 cites·28 claims
- 2190US6251938B1Phenylethylamine derivativesTEVA PHARMA·Filed 1999·Granted Jun 26, 2001·45 cites·28 claims
- 2288USRE39616EAminoindan derivativesTECHNION RES & DEV FOUNDATION·Filed 2005·Granted May 8, 2007·9 cites·58 claims
- 2388US6303650B1Aminoindan derivativesYISSUM RES DEV CO·Filed 1999·Granted Oct 16, 2001·58 cites·40 claims
- 2486US6277886B1Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindanTEVA PHARMA·Filed 1999·Granted Aug 21, 2001·66 cites·21 claims
- 2583US6855711B1Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelatorsYEDA RES & DEV·Filed 2000·Granted Feb 15, 2005·18 cites·26 claims
- 2672US8097608B2Methods for treatment of cardiovascular disorders and diseasesYOUDIM MOUSSA B H·Filed 2006·Granted Jan 17, 2012·1 cites·5 claims
- 2770US8685955B2Neuroprotective iron chelators and pharmaceutical compositions comprising themYOUDIM MOUSSA B H·Filed 2011·Granted Apr 1, 2014·2 cites·9 claims
- 2861US8058442B2Neuroprotective iron chelators and pharmaceutical compositions comprising themYOUDIM MOUSSA·Filed 2003·Granted Nov 15, 2011·4 cites·35 claims
- 2961US2007100001A1Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereofDEV FOUNDATION LTD·Filed 2006·Application pending·0 cites
- 3053US4670394AIsolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:CUS HEALTH·Filed 1984·Granted Jun 2, 1987·12 cites·10 claims
- 3152US2006094783A1Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereofTECHNION RES·Filed 2005·Application pending·0 cites
- 3251US2013217028A1Peripheral blood gene markers for early diagnosis of parkinson's diseaseMANDEL SILVA A·Filed 2011·Application pending·0 cites
- 3350US2009269770A1Methods for evaluation prognosis and follow-up of drug treatment of psychiatric diseases or disordersTECHNION RES & DEV FOUNDATION·Filed 2009·Application pending·0 cites
- 3449US2005171210A1Compositions and methods for treatment of cardiovascular disorders and diseasesRAPPAPORT FAMILY INST FOR RES·Filed 2004·Application pending·0 cites
- 3548US2007281299A1Diagnostic Test For Parkinson's DiseaseYOUDIM MOUSSA B·Filed 2007·Application pending·0 cites
- 3648US2016022572A1Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's diseaseN TO B LTD·Filed 2014·Application pending·0 cites
- 3746US8263655B2Methods for treatment of renal failureBINAH OFER·Filed 2005·Granted Sep 11, 2012·0 cites·12 claims
- 3845US2010221735A1Diagnostic test for parkinson's diseaseTECHNION RES & DEV FOUNDATION·Filed 2010·Application pending·0 cites
- 3943US2014045809A1Corroles for neuroprotection and neurorescueTECHNION RES & DEV FOUNDATION·Filed 2013·Application pending·0 cites
- 4042US2017151192A1Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's diseaseN TO B LTD·Filed 2017·Application pending·0 cites
- 4142US2020354791A1Methods for prognosis or treatment of parkinson's diseaseBIO SHAI LTD·Filed 2018·Application pending·0 cites
- 4241US2014186280A1Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereofVARINEL INC·Filed 2014·Application pending·0 cites
- 4341US2009208979A1Method for identifying antipsychotic drug candidatesTECHNION RES & DEV FOUNDATION·Filed 2009·Application pending·0 cites
- 4440US2008090915A1Method for preventing or attenuating anthracycline-induced cardiotoxicityTECHNION RES & DEV FOUNDATION·Filed 2007·Application pending·0 cites
- 4538US2012095107A1Methods for treatment of cardiovascular disorders and diseasesYOUDIM MOUSSA B H·Filed 2011·Application pending·0 cites
- 4633US8802675B2Neuroprotective multifunctional compounds and pharmaceutical compositions comprising themYOUDIM MOUSSA B H·Filed 2010·Granted Aug 12, 2014·0 cites·18 claims
- 4731US2005191348A1Use of propargylamine as neuroprotective agentTECHNION RES & DEV FOUNDATION·Filed 2005·Application pending·0 cites
- 4828US9034303B2Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereofZURAWSKI JR VINCENT R·Filed 2011·Granted May 19, 2015·0 cites·19 claims
- 4924US9938235B2Compounds with neural protective effect, and preparation and use thereofGUANGZHOU MAGPIE PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Moussa B. H. Youdim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →